The Austrian National Public Health Institute (Gesundheit Österreich GmbH) published a price comparison on the high-cost medicines: The study analyses Austrian prices of 80 high‐cost medicines in…
We aim to contribute to affordable, equitable and sustainable access to safe, effective and quality essential medicines in Austria, Europe and globally.
Comparison of prices of high-cost medicines in Austria and Europe
Publication of the PPRI Pharma Brief Cyprus 2021
The PPRI Secretariat produced an up-to-date concise report of the pharmaceutical system in Cyprus: The “PPRI Pharma Brief Cyprus 2021” describes on a few pages the institutional policy framework…
Article on Biosimilar Policies in Europe
Based on information surveyed from the Pharmaceutical Pricing and Reimbursement Information (PPRI) network, an overview on policies to enhance the uptake of biosimilar medicines in European countries…